MEDICO

Medico Remedies Share Price

 

 

Start SIP in MEDICO

Start SIP

Performance

  • Low
  • ₹49
  • High
  • ₹50
  • 52 Week Low
  • ₹37
  • 52 Week High
  • ₹79
  • Open Price₹50
  • Previous Close₹50
  • Volume16,110
  • 50 DMA₹49.37
  • 100 DMA₹49.00
  • 200 DMA₹49.24

Investment Returns

  • Over 1 Month + 2.02%
  • Over 3 Month -5.12%
  • Over 6 Month + 24.54%
  • Over 1 Year -29.02%

Smart Investing Starts Here Start SIP with Medico Remedies for Steady Growth!

Invest Now

Medico Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 35.8
  • PEG Ratio
  • 0.7
  • Market Cap Cr
  • 406
  • P/B Ratio
  • 6.1
  • Average True Range
  • 2.68
  • EPS
  • 1.37
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.27
  • RSI
  • 52.05
  • MFI
  • 59.35

Medico Remedies Financials

Medico Remedies Technicals

EMA & SMA

Current Price
₹48.92
-0.95 (-1.9%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹49.06
  • 50 Day
  • ₹49.37
  • 100 Day
  • ₹49.00
  • 200 Day
  • ₹49.24

Resistance and Support

49.79 Pivot Speed
  • R3 53.58
  • R2 52.29
  • R1 51.08
  • S1 48.58
  • S2 47.29
  • S3 46.08

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Medico Remedies has an operating revenue of Rs. 171.68 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of 9% is okay, ROE of 16% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its key moving averages, around -0% and 4% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Medico Remedies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-14 Quarterly Results
2025-11-13 Quarterly Results
2025-08-08 Quarterly Results
2025-05-08 Audited Results
Date Purpose Remarks
2023-03-16 Split Rs.0.00 split from Rs. 10/- to Rs. 2/-.
Date Purpose Remarks
2021-11-17 Bonus Rs.0.00 issue of equity shares in the ratio of 3:1 of Rs.. 10/-.

Medico Remedies F&O

Medico Remedies Shareholding Pattern

61.38%
0.49%
22.72%
15.41%

About Medico Remedies

  • NSE Symbol
  • MEDICO
  • BSE Symbol
  • 540937
  • Managing Director
  • Mr. Harshit Haresh Mehta
  • ISIN
  • INE630Y01024

Similar Stocks to Medico Remedies

Medico Remedies FAQs

Medico Remedies share price is ₹48 As on 11 February, 2026 | 12:19

The Market Cap of Medico Remedies is ₹406 Cr As on 11 February, 2026 | 12:19

The P/E ratio of Medico Remedies is 35.8 As on 11 February, 2026 | 12:19

The PB ratio of Medico Remedies is 6.1 As on 11 February, 2026 | 12:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23